Monobasic Sodium Phosphate And Dibasic Sodium Phosphate Tablet
NDC 43386-030
Product Information
Monobasic Sodium Phosphate And Dibasic Sodium Phosphate is a ANDA-approved product labeled by Lupin Pharmaceuticals,inc.. This medication is typically used as a increased large intestinal motility [pe]. It is supplied as a white tablet for oral administration. This product entry covers the primary NDC 43386-030 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
N;03
Code Structure Chart
Product Details
What is NDC 43386-030?
What are the uses of this product?
What are Active Ingredients of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE (UNII: 593YOG76RN)
- SODIUM CATION (UNII: LYR4M0NH37) (Active Moiety)
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)
Which are the Pharmacologic Classes of this product?
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
* Please review the full disclaimer at the bottom of this page.